Enhancement of amygdalin activated with β-D-glucosidase on HepG2 cells proliferation and apoptosis.


The growth inhibition and induction of apoptosis brought by amygdalin and activated with β-D-glucosidase were tested for cytoactivity in HepG2 cells. The MTT viability assay showed that all samples had effects on HepG2 proliferation in dose and time response manners. IC50 of stand-alone amygdalin and activation with β-D-glucosidase on the proliferation of HepG2 cells for 48 h were 458.10 mg/mL and 3.2 mg/mL, respectively. Moreover, apoptotic cells were determined by AO/EB (acridine orange/ethidium bromide) fluorescent staining method and Annexin V-FITC/PI staining flow cytometry cell cycle analysis. With increasing of amygdalin concentration and the incubation time, the apoptotic rate was heightened. Compared with the control, there was significant difference (p<0.01). Together, these findings indicate that amygdalin had no strong anti-HepG2 activity; however the ingredients of amygdalin activated with β-D-glucosidase had a higher and efficient anti-HepG2 activity. It was therefore suggested that this combination strategy may be applicable for treating tumors with a higher activity.

DOI: 10.1016/j.carbpol.2012.05.073

4 Figures and Tables

Citations per Year

Citation Velocity: 8

Averaging 8 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Zhou2012EnhancementOA, title={Enhancement of amygdalin activated with β-D-glucosidase on HepG2 cells proliferation and apoptosis.}, author={Cunshan Zhou and Lichun Qian and Haile Ma and Xiaojie Yu and Youzuo Zhang and Wenjuan Qu and X. W. Zhang and Wei Xia}, journal={Carbohydrate polymers}, year={2012}, volume={90 1}, pages={516-23} }